Abstract
A series of N-benzoyl-4-[(2,6-dichlorobenzoyl)amino]-L-phenylalanine derivatives was prepared in order to optimize the substitution on the N-benzoyl moiety for VCAM/VLA-4 antagonist activity. Disubstitution in the 2- and 6-positions is favored and a range of small alkyl and halogen are tolerated. A model of the bioactive conformation of these compounds is proposed.
MeSH terms
-
Heterocyclic Compounds / chemistry
-
Humans
-
Hydrocarbons, Aromatic
-
Inhibitory Concentration 50
-
Integrin alpha4beta1 / antagonists & inhibitors*
-
Models, Molecular
-
Molecular Mimicry
-
Phenylalanine / analogs & derivatives*
-
Phenylalanine / pharmacology
-
Protein Binding
-
Structure-Activity Relationship
-
Vascular Cell Adhesion Molecule-1 / drug effects*
Substances
-
Heterocyclic Compounds
-
Hydrocarbons, Aromatic
-
Integrin alpha4beta1
-
Vascular Cell Adhesion Molecule-1
-
Phenylalanine